Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Treasury Stock
Abbott Laboratories
Treasury Stock Peer Comparison
Competitive Treasury Stock Analysis
Latest Figures & CAGR of Competitors
Company | Treasury Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Treasury Stock
$-16B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Treasury Stock
$-8.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
Treasury Stock
$-2.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Treasury Stock
$-5B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-15%
|
|
Stryker Corp
NYSE:SYK
|
Treasury Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Treasury Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Treasury Stock?
Treasury Stock
-16B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Treasury Stock amounts to -16B USD.
What is Abbott Laboratories's Treasury Stock growth rate?
Treasury Stock CAGR 10Y
-6%
Over the last year, the Treasury Stock growth was -4%. The average annual Treasury Stock growth rates for Abbott Laboratories have been -18% over the past three years , -11% over the past five years , and -6% over the past ten years .